BB 101 - Bespoke Biotherapeutics
Alternative Names: BB-101 - Bespoke BiotherapeuticsLatest Information Update: 20 Jan 2023
Price :
$50 *
At a glance
- Originator Bespoke Biotherapeutics
- Class Antineoplastics; Cell therapies; Immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Breast cancer
Most Recent Events
- 22 Dec 2022 Bespoke Biotherapeutics receives SBIR grant from the National Science Foundation for BB 101 (Bespoke Biotherapeutics pipeline, December 2022)
- 22 Dec 2022 Early research in Breast cancer in USA (Infusion) (Bespoke Biotherapeutics pipeline, December 2022)